AI-generated summary
The authors report on 40 patients with head and neck squamous cell carcinoma who received radiotherapy and surface low-level laser therapy three times weekly during treatment. Grade 3 mucositis occurred in 15% of patients at week 7, and no grade 4 cases were observed. The study had no control group, so the authors do not compare these rates with patients who did not receive the laser.
- Participants
- 40
- Who or what was studied
- Patients with squamous cell carcinoma of the head and neck receiving definitive or adjuvant radiotherapy between August 2014 and October 2015
- Limits stated in the abstract
- The abstract describes a single-group study without a control group, so the findings cannot be attributed to the laser alone.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on spcare.bmj.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Power
- 350 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, GRADE, Dose, Low-level laser therapy, Photobiomodulation, Oral mucositis. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.